Class 4 drug alert – Caution in Use – Prednisolone tablets 5mg
26 Apr 2019
A Class 4 drug alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for certain batches of Prednisolone tablets 5mg
Class 4 drug alert – Caution in Use – Prednisolone tablets 5mg
Ref: EL (19) A/11
Date 26 April 2019
Prednisolone tablets 5mg
Manufactured by Genethics Europe Ltd (Distributed by Genesis Pharmaceuticals Ltd)
PL 42967/0037
A Class 4 drug alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for certain batches of Prednisolone tablets 5mg as listed in the table below.
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
1809653 |
08/2021 |
1 x 28 |
28/01/2019 |
1809654 |
08/2021 |
1 x 28 |
28/01/2019 |
1809655 |
08/2021 |
1 x 28 |
30/01/2019 |
1809656 |
08/2021 |
1 x 28 |
06/02/2019 |
1809657 |
08/2021 |
1 x 28 |
26/02/2019 |
Genesis Pharmaceuticals Ltd has informed the MHRA that the Braille on the above batches is incorrect; the strength reads as 1mg instead of 5mg. The affected batch numbers of prednisolone tablets 5mg should not be dispensed to patients who rely on Braille alone to determine the strength of their medicine.
Further information can be found on the MHRA section on the GOV.UK website.
Produced by the NPA Pharmacy Services team April 2019.